Skip to main navigation
Skip to search
Skip to main content
Johns Hopkins University Home
Home
Profiles
Research units
Research output
Search by expertise, name or affiliation
Sodium intake and multiple sclerosis activity and progression in BENEFIT
for the BENEFIT Study Group
School of Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
41
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Sodium intake and multiple sclerosis activity and progression in BENEFIT'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Confidence Interval
100%
Multiple Sclerosis
100%
Sodium Intake
100%
Hazard Ratio
60%
Magnetic Resonance Imaging
40%
Imaging Results
40%
5-year Follow-up
40%
Expanded Disability Status Scale
40%
Sodium Levels
40%
Clinically Isolated Syndrome
40%
24-h Urinary Sodium Excretion
40%
Urinary Sodium Excretion
40%
Randomized Clinical Trial
20%
Non-associated
20%
Disability
20%
Magnetic Resonance
20%
Disease Activity
20%
Relapse Rate
20%
Disease Course
20%
Interferon beta-1a
20%
Relative Change
20%
Spot Urine
20%
Multiple Sclerosis Treatment
20%
Result-oriented
20%
Imaging Follow-up
20%
Active Lesions
20%
Salt Intake
20%
Clinically Definite multiple Sclerosis
20%
High-salt Diet
20%
Categorical Data Analysis
20%
Multiple Assessments
20%
Urinary Sodium Concentration
20%
T2 Lesion Volume
20%
Fast Conversions
20%
Cumulative Average
20%
Tanaka Formula
20%
Nursing and Health Professions
Sodium Intake
100%
Multiple Sclerosis
100%
Confidence Interval
83%
Sodium Urine Level
66%
Hazard Ratio
50%
Nuclear Magnetic Resonance Imaging
50%
Expanded Disability Status Scale
33%
Demyelinating Disease
33%
Disease Activity
16%
Sodium Chloride
16%
Urine Sampling
16%
Disease Course
16%
Recurrence Risk
16%
Salt Intake
16%
Lesion Volume
16%
Valerian
16%
Interferon Beta Serine
16%
Medicine and Dentistry
Multiple Sclerosis
100%
Sodium Intake
100%
Magnetic Resonance Imaging
50%
Hazard Ratio
50%
Sodium Excretion
33%
Expanded Disability Status Scale
33%
Clinically Isolated Syndrome
33%
Recurrence Risk
16%
Randomized Clinical Trial
16%
Urine Sampling
16%
Disease Course
16%
Urinary System
16%
Disease Activity
16%
Valerian
16%
Salt Intake
16%
Interferon Beta Serine
16%
High Salt Diet
16%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Sodium Chloride
33%
Demyelinating Disease
33%
Expanded Disability Status Scale
33%
Recurrence Risk
16%
Randomized Clinical Trial
16%
Disease Course
16%
Disease Activity
16%
Valerian
16%
Interferon Beta Serine
16%